Plasma GFAP/NfL ratio promising biomarker candidate to discriminate fronto-temporal dementia subtype FTLD-tau from FTLD-TDP; may possibly classify most patients with sporadic FTLD, whose pathology cannot be determined in life. Cool new study! ja.ma/3ENaa21pic.twitter.com/KnLUm1qeBo
Teacher, Clinical Supervisor
Clinical Associate Professor, Psychiatry
University of Florida
Affiliation is for identification only. All content and opinions are my own.
View more posts
Gator Psychiatry 